The largest database of trusted experimental protocols

Celltiter glo luminescent

Manufactured by Promega
Sourced in United States, Australia

CellTiter-Glo is a luminescent cell viability assay that quantifies the amount of ATP present in metabolically active cells. It uses a luciferase reaction to generate a luminescent signal proportional to the amount of ATP in the sample, which is directly correlated to the number of viable cells.

Automatically generated - may contain errors

37 protocols using celltiter glo luminescent

1

Cell Viability Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The CellTiter-Glo® luminescent cell viability assay (Promega, Milan, Italy) was used to determine the number of viable cells in the culture.
+ Open protocol
+ Expand
2

T Cell Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified CD4+ T cells were stimulated with plate-bound anti-CD3 (145-2C11; Exbio) and soluble anti-CD28 (37-51; Exbio) antibodies. After 48 h of culture, T cell proliferation was assessed with CellTiter-Glo® Luminescent (Promega). The resulting luminescence, which is proportional to the ATP content of the culture, was measured with a Victor 2 luminometer (Wallac, Perkin Elmer Life Science).
+ Open protocol
+ Expand
3

T-cell Proliferation and IL-2 Secretion Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
For proliferation and IL-2 secretion assay, purified CD4+ T cells were stimulated with plate-bound anti-CD3 (145-2C11; Exbio) and soluble anti-CD28 (37-51; Exbio). After 48 h of culture, T-cell proliferation was assessed with CellTiter-Glo Luminescent (Promega). The resulting luminescence, which is proportional to the ATP content of the culture, was measured with a Victor 2 luminometer (Wallac, Perkin Elmer Life Science). IL-2 production was measured with a DuoSet ELISA test (R&D Systems).
+ Open protocol
+ Expand
4

Doxorubicin, Vitamin C, and Antibody Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
PMBL cell lines were treated for 24h with Doxo (0,1ng/ml), VC (1μg/ml) and RmAB (1μg/ml). According to manufacture's protocol the cell viability analysis was performed using the CellTiter-Glo® Luminescent (Promega, Mannheim, Germany.
T-tests were used for statistical comparisons and the statistical significance was defined as p <0.05.
+ Open protocol
+ Expand
5

Assess Cell Viability with ATP and WST-8

Check if the same lab product or an alternative is used in the 5 most similar protocols
The number of viable cells was assessed by measuring intracellular ATP to identify metabolically active cells, using the CellTiter-Glo luminescent cell viability assay (Promega). The number of viable cells after 5 days was assessed by measuring intracellular WST-8 formazan using the Cell Counting Kit-8 (Dojindo Laboratories, Kumamoto, Japan).
+ Open protocol
+ Expand
6

Quantifying Cell Viability and Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To measure ATP consumption, a CellTiter-Glo® luminescent cell viability assay (G7570, Promega) was used. Cells were seeded on 96-well plates (1000 cells/well, triplicates) and treated with specified conditions. After 5-day treatment, cell viability was examined according to the manufacturer’s instructions. In brief, the CellTiter-Glo® solution was applied to each well and incubated at room temperature for 10 min. The intensity of luminescence was measured using a microplate reader (EnSpire, PerkinElemer). Cell viability was calculated relative to DMSO treatment (100%). For the MTT proliferation assay, cells were seeded on 96-well plates (5000 cells/well, triplicates) and cultured under indicated conditions. For each condition, the reagent 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma-Aldrich) was added to the cells and incubated for 4 h at 37 °C (5% CO2). The supernatants were discarded and replaced by 200 µL DMSO to dissolve the formazan product. Absorbance was measured at 570 nm in a plate reader (BMG Labtech).
+ Open protocol
+ Expand
7

Standardized Cell Viability Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
All viability assays were run in 96-wellpates at 72 hours. IC50 viability assays were determined by Cell-Titer Blue (Promega catalog # G8080) and Cell Titer-Glo Luminescent (Promega catalog # G7570). EC50 viability assay was evaluated using the MTT Cell Proliferation Assay Kit (ATCC catalog # 30–1010K).
+ Open protocol
+ Expand
8

Synergistic Drug Effects on NSCLC and LCSC

Check if the same lab product or an alternative is used in the 5 most similar protocols
The inhibitory effect of different drugs was assessed following manufacturer’s protocol on i) NSCLC cell growth by measuring 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide inner salt (MTT, Sigma-Aldrich) dye absorbance of cells, and ii) LCSC cell growth by quantitation of the ATP present in metabolically active cells using CellTiter-Glo® Luminescent (Promega, Southampton, UK). Data were analyzed by the Chou-Talaly method (CalcuSyn software, Biosoft, Cambridge) to determine the combination index (CI), a well-established index of the interaction between two drugs. CI values of <1, =1, and >1 indicate synergistic, additive, and antagonistic effects, respectively.
+ Open protocol
+ Expand
9

Evaluating pSiNP Biocompatibility on hCMEC/D3 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The biocompatibility of modified pSiNPs on the hCMEC/D3 cell line was determined using a CellTiter-Glo® luminescent cell viability assay (Promega, Alexandria, Australia). Briefly, hCMEC/D3 cells were seeded onto a 96-well white opaque polystyrene microplate (Sigma-Aldrich, Macquarie Park, Australia) at a density of 10,000 cells per well and maintained in the cell culture medium for 1 day. Subsequently, cells were treated with different concentrations (5, 10, 25, 50 µg/mL) of surface-modified pSiNPs. Cells without any treatment were used as control, and each condition was triplicated. After incubating cells for 48 h, a CellTiter-Glo® luminescent cell viability assay was used to evaluate the cell viability. Briefly, 100 µL of the solution of the assay kit was added to 100 µL of the medium in each well, and the plates were gently shaken at RT for 15 min. Finally, the luminescence intensity of each sample was obtained using a PerkinElmer EnSpire multimode plate reader, and data were expressed as the mean and standard deviation of 3 replicates.
+ Open protocol
+ Expand
10

Cell Viability Assay with A419259 Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
PMs were seeded in a 96-well plate (1 × 104 cells/well), and A419259 (0.01, 0.1, 0.25, 0.5, and 1 μM) was added to the medium after 12 h. After 4 h, 100 μl of the CellTiter-Glo® luminescent (G7570, Promega, USA) solution was added to the 96-well plate and mixed gently on an orbital shaker at room temperature for 10 min. The resulting fluorescence was measured using a multiscan spectrophotometer (TECAN, SPARK 10M).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!